Sensus Healthcare SRTS
NASDAQ SRTS
$3.41 +0.11 (+3.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Sensus Healthcare (SRTS) Gains from Sales and Divestitures (2021 - 2023)

Updated

Sensus Healthcare (SRTS) recorded Gains from Sales and Divestitures of $42,000 in FY2023, down 99.7% from $12.78 million in FY2022.

Analysis

Sensus Healthcare (SRTS) Gains from Sales and Divestitures (2021 - 2023) Analysis & Trends

  • Per Business Quant data, SRTS's Gains from Sales and Divestitures was $12.78 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Sensus Healthcare 54.32 Mn -25.72 Mn 769,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 42,000.00
Mar 31, 2022 12.78 Mn
Dec 31, 2021 -1,000.00
API Access

Sensus Healthcare Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SRTS&period=max&api_key=YOUR_API_KEY